Home » Topics » BioWorld Science

BioWorld Science
RSS

Gedeon Richter divulges vasopressin V1A receptor antagonists

July 4, 2019

New PRMT5 inhibitors for cancer presented by Lupin

July 4, 2019

GlaxoSmithKline identifies new IDO1 inhibitors for HIV infection

July 4, 2019

Leo Pharma patents PDE4 inhibitors

July 4, 2019

Synergys Biotherapeutics receives NCI funding for development of anti-HER2 antibody fusion candidate

July 4, 2019

FDA grants accelerated approval to Xpovio for relapsed refractory multiple myeloma

July 4, 2019

European Commission approves Ultomiris for adults with PNH

July 4, 2019

Confo Therapeutics and DyNAbind establish GPCR drug discovery collaboration

July 4, 2019

[177Lu]BL-01 as a radiotherapeutic agent for CXCR4-expressing lymphoma

July 4, 2019

FDA grants IND approval to novel PD-1/VEGF bispecific antibody for solid tumors

July 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...